
Medilet Biosciences LLP
About Medilet Biosciences LLP
Data last updated:
Medilet Biosciences LLP is a limited liability partnership (LLP) based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 July 2017 and has been in existence for over 9 years.
The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAK-0204.
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Md Shahwar Alam and Mohd Misbah Alam.
Its latest statement of accounts is for the year ended 31 March 2020. The registered office is at H. No. 220 – A Ground Floor Flat No. 100 Tower – 2 Nai Basti Abul Fazal Enclave Part – 1 Ja, Mia Nagar, New Delhi, Delhi, India – 110025.
Company details
Contact details
Medilet Biosciences LLP's registered office is in New Delhi, Delhi.
- Registered AddressH. No. 220 – A Ground Floor Flat No. 100 Tower – 2 Nai Basti Abul Fazal Enclave Part – 1 Ja, Mia Nagar, New Delhi, Delhi, India – 110025
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Medilet Biosciences LLP
FY 2020 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Income and Expenditure | |||
| Turnover | |||
| Other Income | |||
| Total Income | |||
| Purchases and Direct Costs | |||
| Personnel Expenses | |||
| Administrative Expenses | |||
| Interest | |||
| Depreciation | |||
| Total Expenses | |||
| Profit Before Tax | |||
| Tax | |||
| Profit After Tax | |||
| Profit Transferred to Partners | |||
| Assets and Liabilities | |||
| Partners' Contribution | |||
| Reserves and Surplus | |||
| Secured Loans | |||
| Unsecured Loans | |||
| Trade Payables | |||
| Other Liabilities and Provisions | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Loans and Advances | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Statement of Account and Solvency | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profitability | |||
| Net Profit Margin | |||
| Return on Partners' Funds | |||
| Return on Assets | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Debt to Partners' Funds | |||
| Interest Coverage | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Turnover Growth | |||
| Profit Growth | |||
To see the full financial statements and ratios of Medilet Biosciences LLP, buy the company report.
Designated partners of Medilet Biosciences LLP
Medilet Biosciences has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Md Shahwar Alam | Designated Partner | 17 Jul 2017 | 9 Years 3 Months | Current |
| Mohd Misbah Alam Also directs: Zamius Healthcare LLP | Designated Partner | 17 Jul 2017 | 9 Years 3 Months | Current |
Legal cases
No court or tribunal cases involving Medilet Biosciences LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medilet Biosciences LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Medilet Biosciences LLP; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Medilet Biosciences LLP has 3 designated partner changes on record since 2017: 2 appointments and 1 cessation. The latest: Ejazul Hasan ceased to be Designated Partner on 15 Jun 2020.
Frequently asked questions
Medilet Biosciences is an active limited liability partnership based in New Delhi, Delhi, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 17 July 2017 (9+ years old) and is registered under LLPIN AAK-0204.
Medilet Biosciences has 2 current designated partners:
- Md Shahwar Alam - Designated Partner
- Mohd Misbah Alam - Designated Partner
The latest financial statements of Medilet Biosciences on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 March 2020. Year-wise statements from FY 2018 are in the company report.
The LLPIN (Limited Liability Partnership Identification Number) of Medilet Biosciences is AAK-0204. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Medilet Biosciences was incorporated on 17 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Ejazul Hasan ceased to be Designated Partner on 15 Jun 2020. Md Shahwar Alam was appointed as Designated Partner on 17 Jul 2017. Mohd Misbah Alam was appointed as Designated Partner on 17 Jul 2017.
The registered office of Medilet Biosciences is at H. No. 220 – A Ground Floor Flat No. 100 Tower – 2 Nai Basti Abul Fazal Enclave Part – 1 Ja, Mia Nagar, New Delhi, Delhi, India – 110025.
Medilet Biosciences operates in the pharma industry, in the drug formulation and development segment.
Medilet Biosciences can be reached at its registered office: H. No. 220 – A Ground Floor Flat No. 100 Tower – 2 Nai Basti Abul Fazal Enclave Part – 1 Ja, Mia Nagar, New Delhi, Delhi, India – 110025.
Medilet Biosciences is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.

